417
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

MicroRNA expression profiling involved in MC-LR-induced hepatotoxicity using high-throughput sequencing analysis

, , , , &

References

  • An, F., B. Gong, H. Wang, D. Yu, G. Zhao, L. Lin, W. Tang, H. Yu, S. Bao, and Q. Xie. 2012. MiR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis 17:702–716. doi:10.1007/s10495-012-0704-7.
  • Bouaicha, N., and I. Maatouk. 2004. Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes. Toxicol Lett 148:53–63. doi:10.1016/j.toxlet.2003.12.005.
  • Chen, Y., Y. Zhou, J. Wang, L. Wang, Z. Xiang, D. Li, and X. Han. 2016. Microcystin-Leucine arginine causes cytotoxic effects in sertoli cells resulting in reproductive dysfunction in male mice. Sci Rep 6:39238. doi:10.1038/srep39238.
  • Delire, B., and P. Stärkel. 2015. The Ras/MAPK pathway and hepatocarcinoma: Pathogenesis and therapeutic implications. Eur J Clin Invest 45:609–623. doi:10.1111/eci.12441.
  • Ding, W. X., H. M. Shen, and C. N. Ong. 2001. Critical role of reactive oxygen species formation in microcystin-induced cytoskeleton disruption in primary cultured hepatocytes. J Toxicol Environ Health A 64:507–519. doi:10.1080/152873901753215966.
  • Drobac, D., N. Tokodi, B. Kiprovski, D. Malencic, T. Vazic, S. Nybom, J. Meriluoto, and Z. Svircev. 2017. Microcystin accumulation and potential effects on antioxidant capacity of leaves and fruits of Capsicum annuum. J Toxicol Environ Health A 80:145–154. doi:10.1080/15287394.2016.1259527.
  • Enright, A. J., B. John, U. Gaul, T. Tuschl, C. Sander, and D. S. Marks. 2003. MicroRNA targets in Drosophila. Genome Biol 5:R1. doi:10.1186/gb-2003-5-1-r1.
  • Giovannetti, E., A. Erozenci, J. Smit, R. Danesi, and G. J. Peters. 2012. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Crit Rev Oncol Hematol 81:103–122. doi:10.1016/j.critrevonc.2011.03.010.
  • Grosse, Y., R. Baan, K. Straif, B. Secretan, F. El Ghissassi, and V. Cogliano. 2006. Carcinogenicity of nitrate, nitrite, and cyanobacterial peptide toxins. Lancet Oncol 7:628–629. doi:10.1016/S1470-2045(06)70789-6.
  • Hayashi, T., T. Yamashita, H. Okada, N. Oishi, H. Sunagozaka, K. Nio, T. Hayashi, Y. Hara, Y. Asahina, M. Yoshida, T. Hashiba, T. Suda, T. Shirasaki, Y. Igarashi, K. Miyanouchi, T. Yamashita, M. Honda, and S. Kaneko. 2017. A novel mTOR inhibitor; anthracimycin for the treatment of human hepatocellular carcinoma. Anticancer Res 37:3397–3403. doi:10.21873/anticanres.11706.
  • Hou, L., D. Wang, and A. Baccarelli. 2011. Environmental chemicals and microRNAs. Mutat Res 714:105–112. doi:10.1016/j.mrfmmm.2011.05.004.
  • Jin, B. X., Y. H. Zhang, W. J. Jin, X. Y. Sun, G. F. Qiao, Y. Y. Wei, L. B. Sun, W. H. Zhang, and N. Li. 2015. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis. Sci Rep 5:15026. doi:10.1038/srep15026.
  • Kanehisa, M., M. Araki, S. Goto, M. Hattori, M. Hirakawa, M. Itoh, T. Katayama, S. Kawashima, S. Okuda, T. Tokimatsu, and Y. Yamanishi. 2008. KEGG for linking genomes to life and the environment. Nucl Acids Res 36:D480–D484. doi:10.1093/nar/gkm882.
  • Kwak, P. B., S. Iwasaki, and Y. Tomari. 2010. The microRNA pathway and cancer. Cancer Sci 101:2309–2315. doi:10.1111/j.1349-7006.2010.01683.x.
  • Laplante, M., and D. M. Sabatini. 2012. MTOR signaling in growth control and disease. Cell 149:274–293. doi:10.1016/j.cell.2012.03.017.
  • Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20. doi:10.1016/j.cell.2004.12.035.
  • Li, X., X. Zhang, W. Xie, C. Zhou, Y. Li, and X. Zhang. 2017. Alterations in transcription and protein expressions of HCC-related genes in HepG2 cells caused by microcystin-LR. Toxicol In Vitro 40:115–123. doi:10.1016/j.tiv.2016.12.016.
  • Li, X., Q. Zhao, W. Zhou, L. Xu, and Y. Wang. 2015. Effects of chronic exposure to microcystin-LR on hepatocyte mitochondrial DNA replication in mice. Environ Sci Technol 49:4665–4672. doi:10.1021/es5059132.
  • Ma, J., Y. Li, L. Yao, and X. Li. 2017. Analysis of microRNA expression profiling involved in MC-LR-induced cytotoxicity by high-throughput sequencing. Toxins 9. doi:10.3390/toxins9010023.
  • MacKintosh, C., K. A. Beattie, S. Klumpp, P. Cohen, and G. A. Codd. 1990. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett 264:187–192.
  • Mao, X. Z., T. Cai, J. G. Olyarchuk, and L. P. Wei. 2005. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics 21:3787–3793. doi:10.1093/bioinformatics/bti430.
  • Matter, M. S., T. Decaens, J. B. Andersen, and S. S. Thorgeirsson. 2014. Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends. J Hepatol 60:855–865.
  • Menon, S., and B. D. Manning. 2008. Common corruption of the mTOR signaling network in human tumors. Oncogene 27 (Suppl 2):S43–S51. doi:10.1038/onc.2009.352.
  • Min, L., B. He, and L. Hui. 2011. Mitogen-activated protein kinases in hepatocellular carcinoma development. Semin Cancer Biol 21:10–20. doi:10.1016/j.semcancer.2010.10.011.
  • Vemuganti, R., V. R. Silva, S. L. Mehta, and A. S. Hazell. 2014. Acute liver failure-induced hepatic encephalopathy is associated with changes in microRNA expression profiles in cerebral cortex of the rat. Metab Brain Dis 29:891–899. doi:10.1007/s11011-014-9545-0.
  • Yang, F., Y. Zhou, R. Sun, H. Wei, Y. Li, L. Yin, and Y. Pu. 2014. Biodegradation of microcystin-LR and-RR by a novel microcystin-degrading bacterium isolated from Lake Taihu. Biodegradation 25:447–457. doi:10.1007/s10532-013-9673-y.
  • Yang, Y., W. Liu, R. Ding, L. Xiong, R. Dou, Y. Zhang, and Z. Guo. 2016. Comprehensive expression profiling and functional network analysis of p53-Regulated MicroRNAs in HepG2 cells treated with doxorubicin. Plos One 11:e149227. doi:10.1371/journal.pone.0149227.
  • Young, M. D., M. J. Wakefield, G. K. Smyth, and A. Oshlack. 2010. Gene ontology analysis for RNA-seq: Accounting for selection bias. Genome Biol 11. doi:10.1186/gb-2010-11-2-r14.
  • Zhao, Y., P. Xie, and H. Fan. 2012. Genomic profiling of microRNAs and proteomics reveals an early molecular alteration associated with tumorigenesis induced by MC-LR in mice. Environ Sci Technol 46:34–41. doi:10.1021/es201514h.
  • Zhao, Y., Q. Xue, X. Su, L. Xie, Y. Yan, and A. D. Steinman. 2015. Microcystin-LR induced thyroid dysfunction and metabolic disorders in mice. Toxicology 328:135–141. doi:10.1016/j.tox.2014.12.007.
  • Zhou, Y., Z. Xiang, D. Li, and X. Han. 2014. Regulation of microcystin-LR-induced toxicity in mouse spermatogonia by miR-96. Environ Sci Technol 48:6383–6390. doi:10.1021/es500152m.
  • Zurawell, R. W., H. Chen, J. M. Burke, and E. E. Prepas. 2005. Hepatotoxic cyanobacteria: A review of the biological importance of microcystins in freshwater environments. J Toxicol Environ Health B 8:1–37. doi:10.1080/109374005-90889412.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.